2023 Biopharma Ecosystems 
Frost & Sullivan
MARCH 22, 2024
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% However, the pharma/biopharma industry shows overall stagnant R&D activity. growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022.
BTD Consulting
APRIL 11, 2022
The sponsorship agreement, which begins this year, will continue through 2023 and beyond. ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP and its members have led this success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BTD Consulting
APRIL 11, 2022
The sponsorship agreement, which begins this year, will continue through 2023 and beyond. ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP and its members have led this success.
Frost & Sullivan
MARCH 16, 2025
The Proteomics Ecosystem: Whos Driving Innovation? The proteomics ecosystem is highly consolidated at the top, with a few major players dominating the industry while smaller companies emerge with innovative solutions. of Competitors 80, with revenue greater than $1.0 billion, and Thermo Fisher acquired Olink for $3.1
Frost & Sullivan
JANUARY 23, 2025
The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. South Koreas Investments : Lotte Biologics invested $3.3
Expert insights. Personalized for you.
52 
Let's personalize your content